Refine by
Bioprinting Articles & Analysis
37 news found
Bio-ink is a material used in the 3D bioprinting industry to create structures that can imitate natural tissues and organs. ...
ByMatexcel
In her three years, CELLINK successfully launched multiple bioprinting systems, resulting in an expanded light-based portfolio and solutions targeting the pharmaceutical industry. Under her leadership CELLINK continued to be a driving force in fostering collaboration in the bioprinting space by opening Centres of Excellence at leading institutions in the USA, ...
ByCELLINK
We are very excited to be working alongside CELLINK, leveraging their leading position in the 3D bioprinting Industry while also keeping close communication on future material and devices that can support our long-term vision of producing patient matched bone implants,” said Thea Wulff Olesen, CEO Ossiform. ...
ByCELLINK
“CELLINK Vivoink represents a major milestone in bioprinting technology,” said Cecilia Edebo, CEO of CELLINK. “We are proud to be at the forefront of innovation in the field of regenerative medicine and tissue engineering, and we believe that CELLINK Vivoink will empower researchers to take significant steps toward clinical applications of ...
ByCELLINK
CELLINK, a leading global provider of bioprinting technologies, and the University of California, San Diego (UCSD), a world-renowned research institution, are pleased to announce their partnership to establish a 3D bioprinting Centre of Excellence. ...
ByCELLINK
Carcinotech has established itself as a leader in producing 3D bioprinted Micro-Tumors as well as 3D models based on cancer cell lines, incorporating CELLINK’s technology for automated workflows that have been perfected over the last 3 years. ...
ByCELLINK
3DBio Therapeutics (3DBio), a clinical-stage regenerative medicine company, and the Microtia-Congenital Ear Deformity Institute announced they have conducted a human ear reconstruction using the AuriNovo™ implant, an investigational, patient-matched, 3D-bioprinted living tissue ear implant. The groundbreaking reconstructive procedure in the first-in-human Phase 1/2a ...
“We are pleased to broaden the scope of our agreement with Advanced BioMatrix and the opportunity to include the commercial supply of clinical-grade HyStem as part of ABM’s biomaterials & bioprinting portfolio which is widely available to the cell therapy product development community,” stated Brian M. ...
By combining different technologies, such as robotics, artificial intelligence, computer science, and 3D bioprinting with biology, we enable our customers to improve people's health and lives for the better. ...
Adding Allegro 3D to the portfolio enables BICO Bioprinting to strengthen its position as the global leader in providing 3D bioprinters. ...
BICO Biosciences was awarded an impressive 4 awards in total (Discover Echo 2, Cytena BPS 2), 2 awards were awarded to companies in BICO Bioautomation (Scienion, Cellenion) and the final award was picked up by BICO Bioprinting (Nanoscribe). “We are thrilled to be recognized by the iF committee again this year. ...
This strategic expansion from MatTek aligns with the BICO Group’s strategy to increase accessibility to more sustainable solutions for drug testing and reducing the overall dependency on animal models. “Within the BICO Bioprinting Business Area we are seeing consistent growth in demand for tissue models and alternatives to animal testing. ...
About Prellis Prellis Biologics, Inc. utilizes its proprietary, high-resolution bioprinting technology to recreate and engineer human tissues in vitro. ...
Vancouver, BC, Canada - November 30, 2021 - Aspect Biosystems, a biotechnology company pioneering the development of bioprinted cell therapies as medicines of the future, is pleased to announce a research agreement with the University Health Network (UHN). Through this collaboration, Aspect Biosystems will combine its bioprinting technology with UHN’s ...
The installation of the NGB (Next-Generation Bioprinting) robotic bioprinting platform developed by Poietis in the Advanced Therapy Medicinal Product (ATMP) manufacturing area of the Hôpital de la Conception represents a world premiere and opens up very promising perspectives in regenerative medicine. ...
ByPoietis
Presentation will highlight the development of functional 3D bioprinted co-cultured human hepatocyte spheroids for use as a liver tissue therapeutic Vancouver, BC, Canada, November 3, 2021 - Aspect Biosystems, a biotechnology company pioneering the development of bioprinted cell therapies as medicines of the future, will present new data on its ...
Bioprinted pancreatic tissues successfully regulate blood glucose in animal models of type 1 diabetes Vancouver, BC, Canada, October 13, 2021 - Aspect Biosystems, a biotechnology company pioneering the development of bioprinted cell therapies as medicines of the future, will present the Company’s latest data on its bioprinted pancreas ...
Vancouver, BC, Canada, October 4, 2021 - Aspect Biosystems, a biotechnology company pioneering the development of bioprinted cell therapies as medicines of the future, has announced that President & CEO Tamer Mohamed will present at the annual Cell & Gene Meeting on the Mesa to be held October 12-14, 2021 in Carlsbad, CA. ...
Witek joins as Head of Therapeutic Cell Platforms VANCOUVER, British Columbia – September 28, 2021 – Aspect Biosystems, a biotechnology company pioneering the development of bioprinted cell therapies as medicines of the future, is pleased to announce the addition of regenerative medicine and therapeutic development experts to our leadership team: Jack Harvey and ...
To address these complications, the team at Baylor College of Medicine recently used our REGENHU bioprinter to design a 3D printed biomesh that minimizes postsurgical complications of hernia repair in an animal model. ...
ByRegenhu